Patricia Carr Jazz Pharmaceuticals PLC (JAZZ) insider trading activity

JAZZ Quotes by TradingView

Patricia Carr is SVP, Chief Accounting Officer of Jazz Pharmaceuticals plc. Currently has a direct ownership of 6,596 shares of JAZZ, which is worth approximately $786,507. The most recent transaction as insider was on Jun 07, 2024, when has been sold 163 shares (Ordinary Shares) at a price of $108.83 per share, resulting in proceeds of $17,739. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.6K
0% 3M change
10.19% 12M change
Total Value Held $786,507

Patricia Carr Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 07 2024
SELL
Open market or private sale
$17,739 $108.83 p/Share
163 Reduced 2.41%
6,596 Ordinary Shares
Mar 07 2024
SELL
Open market or private sale
$206,820 $116.98 p/Share
1,768 Reduced 21.14%
6,596 Ordinary Shares
Mar 06 2024
SELL
Open market or private sale
$230,732 $119.18 p/Share
1,936 Reduced 18.8%
8,364 Ordinary Shares
Mar 01 2024
BUY
Grant, award, or other acquisition
-
2,987 Added 22.48%
10,300 Ordinary Shares
Jan 17 2024
BUY
Grant, award, or other acquisition
-
1,327 Added 15.27%
7,363 Ordinary Shares
Aug 29 2023
SELL
Open market or private sale
$20,372 $143.47 p/Share
142 Reduced 2.32%
5,986 Ordinary Shares
Aug 14 2023
SELL
Open market or private sale
$21,829 $138.16 p/Share
158 Reduced 2.51%
6,128 Ordinary Shares
Jun 07 2023
SELL
Open market or private sale
$16,117 $127.92 p/Share
126 Reduced 1.97%
6,286 Ordinary Shares
Mar 15 2023
SELL
Open market or private sale
$136,284 $133.22 p/Share
1,023 Reduced 14.0%
6,286 Ordinary Shares
Mar 05 2023
SELL
Open market or private sale
$161,592 $140.76 p/Share
1,148 Reduced 13.57%
7,309 Ordinary Shares
Mar 03 2023
BUY
Grant, award, or other acquisition
-
2,523 Added 22.98%
8,457 Ordinary Shares
Dec 05 2022
SELL
Open market or private sale
$9,579 $152.06 p/Share
63 Reduced 1.05%
5,934 Ordinary Shares
Aug 15 2022
SELL
Open market or private sale
$339,657 $158.57 p/Share
2,142 Reduced 26.52%
5,934 Ordinary Shares
Aug 15 2022
BUY
Exercise of conversion of derivative security
$226,200 $113.1 p/Share
2,000 Added 20.13%
7,934 Ordinary Shares
Aug 08 2022
SELL
Open market or private sale
$24,068 $152.33 p/Share
158 Reduced 2.53%
6,076 Ordinary Shares
Jun 02 2022
SELL
Open market or private sale
$19,684 $150.26 p/Share
131 Reduced 2.06%
6,234 Ordinary Shares
May 11 2022
SELL
Open market or private sale
$106,502 $147.51 p/Share
722 Reduced 10.38%
6,234 Ordinary Shares
May 10 2022
SELL
Open market or private sale
$39,361 $144.18 p/Share
273 Reduced 3.78%
6,956 Ordinary Shares
May 09 2022
SELL
Open market or private sale
$159,741 $149.71 p/Share
1,067 Reduced 12.86%
7,229 Ordinary Shares
Mar 03 2022
BUY
Grant, award, or other acquisition
-
2,488 Added 23.07%
8,296 Ordinary Shares
Aug 06 2021
SELL
Open market or private sale
$23,230 $147.96 p/Share
157 Reduced 2.54%
6,035 Ordinary Shares
Mar 09 2021
SELL
Open market or private sale
$155,202 $161.5 p/Share
961 Reduced 13.72%
6,045 Ordinary Shares
Mar 08 2021
SELL
Open market or private sale
$175,993 $161.61 p/Share
1,089 Reduced 13.45%
7,006 Ordinary Shares
Feb 25 2021
BUY
Grant, award, or other acquisition
-
1,895 Added 18.97%
8,095 Ordinary Shares
Dec 04 2020
SELL
Open market or private sale
$9,458 $152.55 p/Share
62 Reduced 0.99%
6,200 Ordinary Shares
PC

Patricia Carr

SVP, Chief Accounting Officer
Dublin 4, L2

Track Institutional and Insider Activities on JAZZ

Follow Jazz Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

News

Receive news related to Jazz Pharmaceuticals plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JAZZ